COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus

You are here

Find NINDS Clinical Trials

Find NINDS Clinical Trials

Returning 81 results

Study Title	Location	Status	Disorders
A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients	Maryland	Completed	Multiple Sclerosis
A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)	Multiple U.S. Locations	Completed	Relapsing Remitting Multiple Sclerosis
A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia	Maryland*	Completed	Chronic Dysphagia, Multiple Sclerosis, Parkinson Disease
A Futility Trial of Sirolimus in Multiple System Atrophy	New York	Not Yet Recruiting	Multiple System Atrophy
Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)	Multiple U.S. Locations	Recruiting	FTLD, Progressive Supranuclear Palsy (PSP), Frontotemporal Dementia (FTD), Corticobasal Degeneration (CBD), PPA Syndrome, Behavioral Variant Frontotemporal Dementia (bvFTD), Semantic Variant Primary Progressive Aphasia (svPPA), Nonfluent Variant Primary Progressive Aphasia (nfvPPA), FTD With Amyotrophic Lateral Sclerosis (FTD/ALS), Amyotrophic Lateral Sclerosis (ALS), Oligosymptomatic PSP (oPSP), Corticobasal Syndrome (CBS)
Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis	Maryland*	Not Yet Recruiting	Multiple Sclerosis
Aspirin Or Warfarin To Prevent Stroke	Georgia	Terminated	Stroke, Cerebral Infarction, Atherosclerosis, Constriction, Pathologic
Assessment of Patients With Multiple Sclerosis (MS)	Maryland*	Completed	Herpesviridae Infection, HTLV-I Infection, Multiple Sclerosis, Tropical Spastic Paraparesis, Vasculitis
Augmenting Effects of L-DOPS With Carbidopa and Entacapone	Maryland*	Terminated	Parkinson Disease, Multiple System Atrophy, Autonomic Nervous System Diseases
Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)	International Locations	Active, Not Recruiting	Tuberous Sclerosis, Autism Disorder, Intellectual Disability

Pages